A first look at participation rates in cervical cancer screening programs in Canada

Current Oncology

Volumn 19, Issue 5, 2012, Pages 269-271

  Forte, Tonia ^a   Lockwood, G A ^a,b   McLachlin, C M ^c   Fekete, S ^a   Bryant, H E ^a,d  

^a Canadian Partnership Against Cancer   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; ATTITUDE TO ILLNESS; CANADA; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER SCREENING; HUMAN; HYSTERECTOMY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; SOCIAL PARTICIPATION; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

EID: 84867056225     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.19.1188     Document Type: Article

References (6)

1. Canadian Cancer Society's Steering Committee on Cancer Statistics. Canadian Cancer Statistics 2011. Toronto, ON: Canadian Cancer Society; 2011.
2. Andrae B, Kemetli L, Sparén P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008;100:622-9.
3. Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 2007;45:93-106.
4. Canadian Partnership Against Cancer (cpac). Cervical Cancer Screening in Canada: Monitoring Program Performance 2006-2008. Toronto, ON: cpac; 2011.
5. Moyer VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012;156:880-91.
6. Parkin DM, Bray F. Chapter 2: the burden of hpv-related cancers. Vaccine 2006;24(suppl 3):11-25.